UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.88% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.52% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
BioCryst Pharmaceuticals
BCRX
$2.51B
| $2.26M | ﹤0.01% |
179,534
+27,096
| +18% | +$349K |
|
3052
Hartford Multifactor US Equity ETF
ROUS
$725M
| $2.26M | ﹤0.01% |
63,863
-627
| -1% | -$24.3K |
|
3053
Carlyle Secured Lending
CGBD
$766M
| $2.25M | ﹤0.01% |
196,974
+50,475
| +34% | +$685K |
|
|
IBCE
3054
DELISTED
iShares iBonds Mar 2023 Term Corporate ex-Financials ETF
IBCE
| $2.25M | ﹤0.01% |
92,919
+85,290
| +1,118% | +$2.07M |
|
3055
Nuveen Preferred & Income Opportunities Fund
JPC
$2.93B
| $2.25M | ﹤0.01% |
323,579
-44,243
| -12% | -$346K |
|
|
ALE
3056
DELISTED
Allete
ALE
| $2.24M | ﹤0.01% |
44,819
-4,049
| -8% | -$241K |
|
3057
Group 1 Automotive
GPI
$3.16B
| $2.24M | ﹤0.01% |
15,660
-15,914
| -50% | -$2.73M |
|
3058
ADT
ADT
$5.49B
| $2.24M | ﹤0.01% |
298,704
+180,280
| +152% | +$1.36M |
|
|
DOYU
3059
DouYu International Holdings
DOYU
$134M
| $2.23M | ﹤0.01% |
223,475
-5,373
| -2% | -$67.9K |
|
|
RVNC
3060
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.23M | ﹤0.01% |
82,762
-4,147
| -5% | -$84.1K |
|
3061
Invesco DB Oil Fund
DBO
$390M
| $2.23M | ﹤0.01% |
146,822
+98,355
| +203% | +$1.66M |
|
3062
PUT
MGM Resorts International
MGM
$10.9B
| $2.23M | ﹤0.01% |
75,000
| – | – |
|
3063
RGC Resources
RGCO
$225M
| $2.22M | ﹤0.01% |
105,448
+6,572
| +7% | +$137K |
|
|
VRN
3064
DELISTED
Veren
VRN
| $2.22M | ﹤0.01% |
360,400
+39,537
| +12% | +$282K |
|
|
PR
3065
Permian Resources
PR
$17.8B
| $2.22M | ﹤0.01% |
326,238
+180,604
| +124% | +$1.25M |
|
3066
Icahn Enterprises
IEP
$5.28B
| $2.22M | ﹤0.01% |
44,655
-6,768
| -13% | -$349K |
|
3067
CALL
Roundhill Ball Metaverse ETF
METV
$212M
| $2.22M | ﹤0.01% |
300,000
| – | – |
|
|
JUGG
3068
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $2.22M | ﹤0.01% |
225,539
+100
| +0% | +$978 |
|
|
AUY
3069
DELISTED
Yamana Gold, Inc.
AUY
| $2.21M | ﹤0.01% |
488,978
+376,414
| +334% | +$1.74M |
|
3070
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
| $2.21M | ﹤0.01% |
136,787
-19,467
| -12% | -$346K |
|
3071
Visteon
VC
$2.8B
| $2.21M | ﹤0.01% |
20,825
-37,890
| -65% | -$4.52M |
|
3072
Valmont Industries
VMI
$9.5B
| $2.21M | ﹤0.01% |
8,223
-13,012
| -61% | -$3.44M |
|
|
NOVA
3073
CALL
DELISTED
Sunnova Energy
NOVA
| $2.21M | ﹤0.01% |
100,000
-195,100
| -66% | -$4.73M |
|
3074
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
| $2.21M | ﹤0.01% |
23,455
+3,191
| +16% | +$347K |
|
|
CINC
3075
PUT
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $2.2M | ﹤0.01% |
+67,000
| New | +$1.89M |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2022 filing shows 1,175 new, 4,825 increased, 3,846 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,175 new positions and closed 1,024 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.